Lantheus Holdings, Inc. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability
Lantheus Holdings, Inc. (LNTH) had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability of $12.60 million as of 2020-06-30, per its 10-Q filed 2020-07-31.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability · last filed 2020-07-31
- 2020-06-30: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability $12.60M.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability |
|---|---|
| 2020-06-30 | $12.60M 10-Q · filed 2020-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |